Skip to main content

and
  1. No Access

    Article

    Alternative donor transplants for patients with advanced hematologic malignancies, conditioned with thiotepa, cyclophosphamide and antithymocyte globulin

    Preparative regimens without total body irradiation (TBI) have been reported for alternative donor hemopoietic stem cell transplants (HSCT). Between 7 September 1994 and 7 June 1999 48 patients with advanced h...

    T Lamparelli, MT van Lint, F Gualandi, AM Raiola, M Barbanti in Bone Marrow Transplantation (2000)

  2. No Access

    Article

    Bioavailability of Desmin, a low molecular weight dermatan sulfate, affer subcutaneous administration to healthy volunteers

    The bioavailability of two different s.c. doses of Desmin (a new low molecular weight dermatan sulfate) was evaluated in 12 healthy volunteers (6 men, 6 women aged 22–45 years) who were injected, on 3 separate...

    M. Miglioli, L. Pironi, E. Ruggeri, C. Serra in International Journal of Clinical and Labo… (1997)

  3. No Access

    Article

    Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience

    This is a report on 60 consecutive patients with chronic myeloid leukemia (CML) who received an allogeneic bone marrow transplant (BMT) in this Unit. Donors were HLA-identical siblings (SIB) (n = 36) or unrelated...

    T Lamparelli, MT Van Lint, F Gualandi, D Occhini, M Barbanti in Bone Marrow Transplantation (1997)

  4. Article

    Non-enzymatic glycation reduces heparin cofactor II anti-thrombin activity

    The effects of non-enzymatic glycation on heparin cofactor II activity, at glucose concentrations which might be expected in physiological or diabetic conditions have been evaluated in this study. Radiolabelle...

    Dr. A. Ceriello, E. Marchi, M. Barbanti, M. R. Milani, D. Giugliano in Diabetologia (1990)

  5. Article

    Evidence for a hyperglycaemia-dependent decrease of antithrombin III-thrombin complex formation in humans

    In the presence of increased levels of fibrinopeptide A, decreased antithrombin III biological activity, and thrombin-antithrombin III complex levels are seen in diabetic patients. Induced-hyperglycaemia in di...

    Dr. A. Ceriello, D. Giugliano, A. Quatraro, E. Marchi, M. Barbanti in Diabetologia (1990)

  6. No Access

    Chapter and Conference Paper

    Antigen Society #15 Report (Bw4 and Bw6)

    During the Tenth Workshop, 27 anti-sera in the Antigen Society and 22 anti-sera in the Core serology serum set were provided for the serologic analysis of the supertypic HLA-B locus specificities Bw4 and Bw6. ...

    A. Arnaiz-Villena, M. Belvedere, F. Decary, M. Fotino, E. Heise in Immunobiology of HLA (1989)

  7. No Access

    Article

    Effect of SAS 650—Furofenac®) on malondialydehyde production by platelets

    The activity of SAS 650, a new anti-inflammatory drug, onex vivo andin vitro MDA production by platelets was compared to that of aspirin. The drug induced dose-dependent inhibition ofin vitro MDA production by ra...

    G. P. Corbelli, L. Stanzani, R. Mastacchi, M. Barbanti, L. Montecchi in Agents and Actions (1984)